Squarepoint Ops LLC grew its position in shares of Hill-Rom Holdings, Inc. (NYSE:HRC) by 1,311.2% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 143,337 shares of the medical technology company’s stock after buying an additional 133,180 shares during the period. Squarepoint Ops LLC owned about 0.22% of Hill-Rom worth $12,692,000 as of its most recent SEC filing.
A number of other large investors have also recently added to or reduced their stakes in HRC. Russell Investments Group Ltd. lifted its holdings in Hill-Rom by 52.1% during the 3rd quarter. Russell Investments Group Ltd. now owns 20,406 shares of the medical technology company’s stock worth $1,927,000 after buying an additional 6,990 shares during the last quarter. LSV Asset Management bought a new position in Hill-Rom during the 3rd quarter worth approximately $715,000. Commonwealth Bank of Australia bought a new position in Hill-Rom during the 3rd quarter worth approximately $339,000. Swiss National Bank lifted its holdings in Hill-Rom by 0.8% during the 3rd quarter. Swiss National Bank now owns 115,600 shares of the medical technology company’s stock worth $10,913,000 after buying an additional 900 shares during the last quarter. Finally, Teachers Retirement System of The State of Kentucky lifted its holdings in Hill-Rom by 169.4% during the 3rd quarter. Teachers Retirement System of The State of Kentucky now owns 35,172 shares of the medical technology company’s stock worth $3,320,000 after buying an additional 22,116 shares during the last quarter. 84.19% of the stock is currently owned by institutional investors.
Shares of NYSE HRC traded up $0.61 during mid-day trading on Thursday, hitting $104.62. The company had a trading volume of 848 shares, compared to its average volume of 461,556. The company has a market cap of $6.96 billion, a price-to-earnings ratio of 22.02, a price-to-earnings-growth ratio of 1.80 and a beta of 0.96. Hill-Rom Holdings, Inc. has a 12 month low of $81.82 and a 12 month high of $108.10. The company has a current ratio of 1.70, a quick ratio of 1.25 and a debt-to-equity ratio of 1.17.
Hill-Rom (NYSE:HRC) last announced its quarterly earnings results on Friday, January 25th. The medical technology company reported $1.02 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.98 by $0.04. The business had revenue of $683.50 million for the quarter, compared to the consensus estimate of $676.39 million. Hill-Rom had a return on equity of 21.23% and a net margin of 7.21%. The business’s revenue was up 2.1% on a year-over-year basis. During the same quarter last year, the business posted $0.92 EPS. As a group, equities analysts forecast that Hill-Rom Holdings, Inc. will post 5.04 earnings per share for the current fiscal year.
The firm also recently announced a quarterly dividend, which will be paid on Friday, March 29th. Shareholders of record on Friday, March 22nd will be paid a dividend of $0.21 per share. The ex-dividend date is Thursday, March 21st. This represents a $0.84 annualized dividend and a yield of 0.80%. This is an increase from Hill-Rom’s previous quarterly dividend of $0.20. Hill-Rom’s payout ratio is presently 16.84%.
A number of research analysts have commented on HRC shares. ValuEngine raised Hill-Rom from a “hold” rating to a “buy” rating in a report on Saturday, January 19th. Morgan Stanley cut their price target on Hill-Rom from $100.00 to $98.00 and set an “equal weight” rating on the stock in a report on Wednesday, January 2nd. Needham & Company LLC reissued a “buy” rating and issued a $116.00 price target on shares of Hill-Rom in a report on Monday, March 11th. UBS Group began coverage on Hill-Rom in a report on Tuesday, November 27th. They issued a “buy” rating and a $115.00 price target on the stock. Finally, Zacks Investment Research raised Hill-Rom from a “hold” rating to a “buy” rating and set a $108.00 price target on the stock in a report on Thursday, December 13th. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and six have assigned a buy rating to the company’s stock. Hill-Rom currently has an average rating of “Buy” and an average price target of $103.78.
COPYRIGHT VIOLATION NOTICE: “Hill-Rom Holdings, Inc. (HRC) Shares Bought by Squarepoint Ops LLC” was reported by Zolmax and is the property of of Zolmax. If you are reading this story on another site, it was illegally copied and reposted in violation of US and international copyright & trademark laws. The correct version of this story can be accessed at https://zolmax.com/investing/hill-rom-holdings-inc-hrc-shares-bought-by-squarepoint-ops-llc/2979906.html.
Hill-Rom Holdings, Inc operates as a medical technology company worldwide. It operates in three segments: Patient Support Systems, Front Line Care, and Surgical Solutions. The company offers medical surgical beds, intensive care unit beds, and bariatric patient beds, lifts and other patient mobility devices, non-invasive therapeutic products and surfaces, and information technologies and software solutions; and medical equipment management services, as well as sells equipment service contracts for its capital equipment.
Recommended Story: What is the S&P 500 Index?
Receive News & Ratings for Hill-Rom Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hill-Rom and related companies with MarketBeat.com's FREE daily email newsletter.